The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy
Abstract
OBJECTIVE: Recent studies have suggested benefits of bone marrow cell transplantation for the regeneration of ischemic cardiac tissue. To extend the potential of cell transplantation, we assessed this treatment in a mouse model of acute nonischemic doxorubicin-induced cardiomyopathy. METHODS: To allow detection of engrafted cells, we used transgenic mice expressing the nuclear-located LacZ under the control of either desmin or vimentin promoters, which identify muscle lineage and mesenchymal cells, respectively. All transplanted cells were also labeled with the fluorescent dye DIL. One week after the administration of doxorubicin (15 mg/kg), mice were intramyocardially injected with either allogeneic unpurified bone marrow cells (6 x 10(6) in 30 microl, n=59) or purified sca-1(pos) cells (4 x 10(5) in 30 microl, n=22). In parallel, control normal mice received only unpurified bone marrow cells (n=28). Hearts were harvested at serial intervals until 2 weeks after transplantation and analyzed by immunohistochemistry to assess the degree of engraftment and transplanted cell differentiation. RESULTS: In control mice, no differentiation of bone marrow cells was detected. In contrast, unpurified bone marrow cells grafted into diseased myocardium featured two successive phases of cell differentiation. The first yielded cells with a mesenchymal phenotype (44.1+/-10.1 cells/3 x 10(-2) mm(3) at 2 days), was transient and lasted 1 week. The second phase was characterized by cells with a muscular phenotype detected in a small number of cells (5.6+/-2.3 cells/3 x 10(-2) mm(3) at 7 days). Two weeks after transplantation, some of these cells appeared phenotypically close to cardiomyocytes, as evidenced by morphology and positive staining for myosin binding protein C, vinculin and myosin heavy chain. In sca-1(pos) hematopoietic progenitor grafted mice hearts, no transdifferentiation into cardiac cells was detected at any time point. CONCLUSION: These data support the hypothesis of the potential for a myogenic differentiation of bone marrow cells following engraftment in a nonischemic model of global cardiomyopathy. Bone marrow-derived cells amenable to cardiac differentiation are present in total unpurified bone marrow but not in the sca-1(pos) hematopoietic progenitor cell population. However, the very small number of transdifferentiated cells raises concerns over their functional efficacy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Doxorubicin (DOX)-induced HF is a suitable model to perform mechanistic evaluation of non-ischemic CVD. It mimics severe non-ischemic human cardiomyopathy and LV dysfunction. It is achieved by giving a single dose of DOX (20 mg/kg) to the animal, causing clinical symptoms reminiscent of non-ischemic HF [90].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [90]
Citations
Cites
Bone marrow cells regenerate infarcted myocardium
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., et al. (2001) · Nature · doi:10.1038/35070587 · Cited by 5,155
Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., Homma, S., Edwards, N. M., & Itescu, S. (2001) · Nature Medicine · doi:10.1038/86498 · Cited by 2,540
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002) · Circulation · doi:10.1161/hc0102.101442 · Cited by 2,234
Mobilized bone marrow cells repair the infarcted heart, improving function and survival
Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I., Quaini, F., Nadal-Ginard, B., Bodine, D. M., Leri, A., & Anversa, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181177898 · Cited by 2,086
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., Entman, M. L., Michael, L. H., Hirschi, K. K., & Goodell, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12150 · Cited by 1,960
Tateishi-Yuyama, E., Matsubara, H., Murohara, T., Ikeda, U., Shintani, S., Masaki, H., Amano, K., Kishimoto, Y., Yoshimoto, K., Akashi, H., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09670-8 · Cited by 1,734
Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation
Taylor, D. A., Atkins, B. Z., Hungspreugs, P., Jones, T. R., Reedy, M. C., Hutcheson, K. A., Glower, D. D., & Kraus, W. E. (1998) · Nature Medicine · doi:10.1038/nm0898-929 · Cited by 1,152
Myoblast transplantation for heart failure
Menasché, P., Hagège, A. A., Scorsin, M., Pouzet, B., Desnos, M., Duboc, D., Schwartz, K., Vilquin, J.-T., & Marolleau, J.-P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03617-5 · Cited by 1,124
Caveolins, Liquid-Ordered Domains, and Signal Transduction
Smart, E. J., Graf, G. A., McNiven, M. A., Sessa, W. C., Engelman, J. A., Scherer, P. E., Okamoto, T., & Lisanti, M. P. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7289 · Cited by 1,006
Autologous Transplantation of Bone Marrow Cells Improves Damaged Heart Function
Tomita, S., Li, R.-K., Weisel, R. D., Mickle, D. A. G., Kim, E.-J., Sakai, T., & Jia, Z.-Q. (1999) · Circulation · doi:10.1161/01.cir.100.suppl_2.ii-247 · Cited by 1,003
Cited by
Nygren, J. M., Jovinge, S., Breitbach, M., Säwén, P., Röll, W., Hescheler, J., Taneera, J., Fleischmann, B. K., & Jacobsen, S. E. W. (2004) · Nature Medicine · doi:10.1038/nm1040 · Cited by 1,037
Concise Review: Mesenchymal Stromal Cells: Potential for Cardiovascular Repair
Psaltis, P. J., Zannettino, A. C. W., Worthley, S. G., & Gronthos, S. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0428 · Cited by 303
Cardiovascular disease models: A game changing paradigm in drug discovery and screening
Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223
Small mammalian animal models of heart disease.
Camacho, P., Fan, H., Liu, Z., & He, J. (2016) · PubMed · Cited by 174
Mesenchymal Stem Cells and the Treatment of Cardiac Disease
Minguell, J. J., & Erices, A. A. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100105 · Cited by 170
Metadata
- Authors
- Agbulut, O.
- Affiliations
- Inserm (FR)
- Corresponding author
- Agbulut, O
- ORCID
- Agbulut, O
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-05-01
- Volume
- 58
- Issue
- 2
- Pages
- 451-459
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W1988063552
- Cited by
- 68
- References
- 40
- Citations by year
- 2026: 1 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 4 · 2013: 2 · 2012: 5
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Keywords
- bone marrow cell transplantation, doxorubicin-induced cardiomyopathy, cell differentiation, myogenesis, engraftment, cardiac regeneration, non-ischemic cardiomyopathy, mesenchymal phenotype, myosin heavy chain
- MeSH terms
- Ataxins, Ataxin-1, Animals, Antibiotics, Antineoplastic, Bone Marrow Cells, Cell Differentiation, Desmin, Doxorubicin, Fluorescent Antibody Technique, Heart Failure, Hematopoietic Stem Cells, Lac Operon, Mice, Inbred C57BL, Mice, Transgenic, Nerve Tissue Proteins, Nuclear Proteins, Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantation, Models, Animal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy. https://app.cochat.ai/papers/10.1016/s0008-6363(03)00281-5
- The paper
- Agbulut, O. (2003). Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy. Cardiovascular Research. https://doi.org/10.1016/s0008-6363(03)00281-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.